Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The dyslipidaemia market

Nature Reviews Drug Discovery volume 13, pages 807–808 (2014)Cite this article

Subjects

Current therapeutic options

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: Shifting composition of the dyslipidaemia market.

References

  1. World Health Organization. Cardiovascular diseases (CVDs) Factsheet N° 316. [online], (2013).

  2. Datamonitor Healthcare. Epidemiology: Dyslipidemia (December 2013).

Download references

Author information

Affiliations

  1. Datamonitor Healthcare, Christchurch Court, 10–15 Newgate Street, London, EC1A 7AZ, United Kingdom

    Victoria Hudson

Authors
  1. Victoria Hudson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Victoria Hudson.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hudson, V. The dyslipidaemia market. Nat Rev Drug Discov 13, 807–808 (2014). https://doi.org/10.1038/nrd4475

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4475

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing